Living to 120: The Biotech Longevity Revolution

FDA approves the first senolytic drug therapy for human trials

📅January 20, 2026
⏱️5 min read

Treating Aging as a Disease

For the first time, regulators are acknowledging 'aging' as a treatable condition. New therapies targeting senescent 'zombie' cells have shown to reverse biological age in primates by 15%.

AI Drug Discovery

What used to take 10 years now takes 10 months. AlphaFold-5 has mapped the entire human proteome's interaction network, allowing researchers to simulate drug effects in silico with 99% accuracy.

The Silver Economy

As life expectancy jumps, the entire retirement planning industry is being disrupted. 'Life-cycle funds' are extending their target dates to age 100 and beyond.

Personalized Medicine

At-home DNA sequencers are now as common as microwaves, allowing for daily health monitoring and hyper-personalized nutritional supplements.

← Back to News